
Phi Hoang
Examiner (ID: 1921, Phone: (571)270-3417 , Office: P/2613 )
| Most Active Art Unit | 2613 |
| Art Unit(s) | 2678, 2619, 2628, 2613, 4178 |
| Total Applications | 1057 |
| Issued Applications | 820 |
| Pending Applications | 71 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13247951
[patent_doc_number] => 10136645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Antimicrobial composition
[patent_app_type] => utility
[patent_app_number] => 15/546073
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27642
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546073
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546073 | Antimicrobial composition | Feb 4, 2016 | Issued |
Array
(
[id] => 12117207
[patent_doc_number] => 20180000793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis'
[patent_app_type] => utility
[patent_app_number] => 15/545645
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20620
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545645 | Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis | Feb 4, 2016 | Abandoned |
Array
(
[id] => 16197461
[patent_doc_number] => 10722599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Lipid assemblies and uses thereof and some pH and electrostatic modulating lipids to be used in said assemblies
[patent_app_type] => utility
[patent_app_number] => 15/548601
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 25190
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548601
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548601 | Lipid assemblies and uses thereof and some pH and electrostatic modulating lipids to be used in said assemblies | Feb 3, 2016 | Issued |
Array
(
[id] => 14728987
[patent_doc_number] => 10383872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Pharmaceutical compositions comprising phenylaminopyrimidine derivative
[patent_app_type] => utility
[patent_app_number] => 16/062320
[patent_app_country] => US
[patent_app_date] => 2016-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 9374
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062320 | Pharmaceutical compositions comprising phenylaminopyrimidine derivative | Jan 29, 2016 | Issued |
Array
(
[id] => 14728987
[patent_doc_number] => 10383872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Pharmaceutical compositions comprising phenylaminopyrimidine derivative
[patent_app_type] => utility
[patent_app_number] => 16/062320
[patent_app_country] => US
[patent_app_date] => 2016-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 9374
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062320 | Pharmaceutical compositions comprising phenylaminopyrimidine derivative | Jan 29, 2016 | Issued |
Array
(
[id] => 14728987
[patent_doc_number] => 10383872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Pharmaceutical compositions comprising phenylaminopyrimidine derivative
[patent_app_type] => utility
[patent_app_number] => 16/062320
[patent_app_country] => US
[patent_app_date] => 2016-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 9374
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062320 | Pharmaceutical compositions comprising phenylaminopyrimidine derivative | Jan 29, 2016 | Issued |
Array
(
[id] => 14728987
[patent_doc_number] => 10383872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Pharmaceutical compositions comprising phenylaminopyrimidine derivative
[patent_app_type] => utility
[patent_app_number] => 16/062320
[patent_app_country] => US
[patent_app_date] => 2016-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 9374
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062320 | Pharmaceutical compositions comprising phenylaminopyrimidine derivative | Jan 29, 2016 | Issued |
Array
(
[id] => 13182101
[patent_doc_number] => 10106551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Monothiol mucolytic agents
[patent_app_type] => utility
[patent_app_number] => 15/010510
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 32238
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15010510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/010510 | Monothiol mucolytic agents | Jan 28, 2016 | Issued |
Array
(
[id] => 12117218
[patent_doc_number] => 20180000804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'PARENTERAL AND TOPICAL COMPOSITIONS FOR PAIN'
[patent_app_type] => utility
[patent_app_number] => 15/546279
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5113
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546279
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546279 | Parenteral and topical compositions for pain | Jan 27, 2016 | Issued |
Array
(
[id] => 12150068
[patent_doc_number] => 20180021333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EBOLA VIRUS DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/546362
[patent_app_country] => US
[patent_app_date] => 2016-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6974
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546362 | Methods and pharmaceutical compositions for the treatment of ebola virus disease | Jan 26, 2016 | Issued |
Array
(
[id] => 12124981
[patent_doc_number] => 20180008567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/542668
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6116
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542668
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542668 | COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME | Jan 14, 2016 | Abandoned |
Array
(
[id] => 11844516
[patent_doc_number] => 09732061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Cinnoline derivatives useful as CB-1 receptor inverse agonists'
[patent_app_type] => utility
[patent_app_number] => 14/992464
[patent_app_country] => US
[patent_app_date] => 2016-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35844
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14992464
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/992464 | Cinnoline derivatives useful as CB-1 receptor inverse agonists | Jan 10, 2016 | Issued |
Array
(
[id] => 13714229
[patent_doc_number] => 20170368069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => USE OF 4-(4-FLUORO-2-METHOXYPHENYL)-N--1,3,5-TRIAZIN-2-AMINE FOR TREATING LEUKEMIAS
[patent_app_type] => utility
[patent_app_number] => 15/543228
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543228
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/543228 | USE OF 4-(4-FLUORO-2-METHOXYPHENYL)-N--1,3,5-TRIAZIN-2-AMINE FOR TREATING LEUKEMIAS | Jan 7, 2016 | Abandoned |
Array
(
[id] => 13193883
[patent_doc_number] => 10111842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Eutectic solvents and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/540688
[patent_app_country] => US
[patent_app_date] => 2015-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 21008
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540688
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/540688 | Eutectic solvents and uses thereof | Dec 29, 2015 | Issued |
Array
(
[id] => 12116499
[patent_doc_number] => 20180000085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'USE OF PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/540804
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30206
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540804
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/540804 | USE OF PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | Dec 20, 2015 | Abandoned |
Array
(
[id] => 10821976
[patent_doc_number] => 20160168140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS'
[patent_app_type] => utility
[patent_app_number] => 14/965759
[patent_app_country] => US
[patent_app_date] => 2015-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 94507
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14965759
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/965759 | HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS | Dec 9, 2015 | Abandoned |
Array
(
[id] => 13699507
[patent_doc_number] => 20170360708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => SOLID DISPERSION OF DECOQUINATE, A PREPARATION PROCESS AND ITS APPLICATION
[patent_app_type] => utility
[patent_app_number] => 15/531244
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531244
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/531244 | Solid dispersion of decoquinate, a preparation process and its application | Dec 7, 2015 | Issued |
Array
(
[id] => 16042921
[patent_doc_number] => 10683319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Phosphoramidates for the treatment of hepatitis B virus
[patent_app_type] => utility
[patent_app_number] => 15/536237
[patent_app_country] => US
[patent_app_date] => 2015-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 17323
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/536237 | Phosphoramidates for the treatment of hepatitis B virus | Dec 6, 2015 | Issued |
Array
(
[id] => 13968223
[patent_doc_number] => 10213444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Composition and method for treating bipolar disorder
[patent_app_type] => utility
[patent_app_number] => 15/532851
[patent_app_country] => US
[patent_app_date] => 2015-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2779
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/532851 | Composition and method for treating bipolar disorder | Dec 3, 2015 | Issued |
Array
(
[id] => 12997391
[patent_doc_number] => 10022341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Methods of preventing neurodegeneration of association cortex in a mammal
[patent_app_type] => utility
[patent_app_number] => 15/532420
[patent_app_country] => US
[patent_app_date] => 2015-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 52
[patent_no_of_words] => 15542
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532420
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/532420 | Methods of preventing neurodegeneration of association cortex in a mammal | Dec 1, 2015 | Issued |